Who owns Spero Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SPRO from SEC Form 13F filings across 61 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 61 institutions disclosed 25.8M shares of Spero Therapeutics, Inc. worth $31.3M — about 44.6% of shares outstanding; the largest disclosed holder is GSK plc. Source: SEC Form 13F filings, parsed by EvidInvest.
61
13F holders
$31.3M
value, 2026 filers
44.6%
of shares outstanding (25.8M sh)
19
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of SPRO's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | GSK plc | 9.2M | $11.1M | 2.2% | 15.9% | 0.0% |
| 2 | Pfizer Inc | 2.4M | $2.9M | 1.8% | 4.1% | 0.0% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $2.5M | 0.0% | 3.5% | 0.0% |
| 4 | MACKENZIE FINANCIAL CORPNEW | 1.8M | $2.2M | 0.0% | 3.2% | new |
| 5 | RENAISSANCE TECHNOLOGIES LLC | 1.4M | $1.7M | 0.0% | 2.4% | +48.7% |
| 6 | Affinity Asset Advisors, LLCNEW | 1.3M | $1.6M | 0.1% | 2.2% | new |
| 7 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 997,123 | $1.2M | 0.0% | 1.7% | +199.5% |
| 8 | Verdad Advisers, LP | 805,702 | $974,900 | 1.0% | 1.4% | +1469.5% |
| 9 | RAYMOND JAMES FINANCIAL INC | 755,633 | $914,316 | 0.0% | 1.3% | +44.8% |
| 10 | CITADEL ADVISORS LLCNEW | 725,988 | $878,445 | 0.0% | 1.3% | new |
| 11 | BlackRock, Inc. | 594,258 | $719,053 | 0.0% | 1% | 0.0% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 499,271 | $604,426 | 0.0% | 0.9% | -11.8% |
| 13 | VANGUARD FIDUCIARY TRUST CO | 287,648 | $348,054 | 0.0% | 0.5% | 0.0% |
| 14 | TWO SIGMA INVESTMENTS, LP | 267,195 | $323,306 | 0.0% | 0.5% | -30.2% |
| 15 | MORGAN STANLEY | 258,645 | $312,961 | 0.0% | 0.4% | +28198.1% |
| 16 | STATE STREET CORP | 251,251 | $304,014 | 0.0% | 0.4% | +17.0% |
| 17 | HRT FINANCIAL LPNEW | 204,964 | $248,000 | 0.0% | 0.4% | new |
| 18 | PRUDENTIAL FINANCIAL INC | 204,663 | $247,642 | 0.0% | 0.4% | +1867.9% |
| 19 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 201,937 | $244,344 | 0.0% | 0.3% | -73.4% |
| 20 | MARSHALL WACE, LLPNEW | 195,416 | $236,453 | 0.0% | 0.3% | new |
| 21 | Shay Capital LLC | 166,030 | $200,896 | 0.0% | 0.3% | +129.4% |
| 22 | Invesco Ltd. | 165,530 | $200,291 | 0.0% | 0.3% | +157.7% |
| 23 | Employees Retirement System of TexasNEW | 125,081 | $151,000 | 0.0% | 0.2% | new |
| 24 | NORTHERN TRUST CORP | 108,274 | $131,012 | 0.0% | 0.2% | 0.0% |
| 25 | XTX Topco Ltd | 104,323 | $126,231 | 0.0% | 0.2% | +106.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.